Ligand-Binding Assays
Intertek offers comprehensive expertise in method development and validation of ligand-binding assays to support pharmacokinetic assessments of biologics and biosimilars.
Ligand-binding assays (LBA) have made a major impact on biomedical research since their inception in the late 1950's. For GLP bioanalytical support of macromolecules in preclinical and clinical development, quantitative immunoassays that rely on specific antibodies binding to a target analyte represent the best known examples of quantitative ligand-binding assays. Such ligand-binding assays form the basis of analyzing and quantifying biologics and biosimilars in pharmacokinetic and toxicokinetic studies. Typical assay formats include:
- ELISA
- ECL
- RIA
For more information click here.
Related Services for Macromolecules
Request more information to see how Intertek can help your organization with Ligand-Binding Assays.